vs
Hagerty, Inc.（HGTY）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Hagerty, Inc.的季度营收约是Orthofix Medical Inc.的1.8倍（$388.1M vs $219.9M），Hagerty, Inc.净利率更高（7.4% vs -1.0%，领先8.4%），Hagerty, Inc.同比增速更快（16.5% vs 2.0%），Hagerty, Inc.自由现金流更多（$194.5M vs $16.8M），过去两年Hagerty, Inc.的营收复合增速更高（19.5% vs 8.0%）
哈格蒂（Hagerty, Inc.）是美国知名汽车生活方式及会员服务企业，同时是全球规模最大的经典老爷车特种保险供应商，总部位于密歇根州特拉弗斯城，业务范围覆盖加拿大、德国及英国市场。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
HGTY vs OFIX — 直观对比
营收规模更大
HGTY
是对方的1.8倍
$219.9M
营收增速更快
HGTY
高出14.5%
2.0%
净利率更高
HGTY
高出8.4%
-1.0%
自由现金流更多
HGTY
多$177.6M
$16.8M
两年增速更快
HGTY
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $388.1M | $219.9M |
| 净利润 | $28.6M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 10.2% | 0.2% |
| 净利率 | 7.4% | -1.0% |
| 营收同比 | 16.5% | 2.0% |
| 净利润同比 | 238.4% | 92.4% |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HGTYOFIX
| Q4 25 | $388.1M | $219.9M | ||
| Q3 25 | $380.0M | $205.6M | ||
| Q2 25 | $368.7M | $203.1M | ||
| Q1 25 | $319.6M | $193.6M | ||
| Q4 24 | $333.2M | $215.7M | ||
| Q3 24 | $323.4M | $196.6M | ||
| Q2 24 | $313.2M | $198.6M | ||
| Q1 24 | $271.7M | $188.6M |
净利润HGTYOFIX
| Q4 25 | $28.6M | $-2.2M | ||
| Q3 25 | $46.2M | $-22.8M | ||
| Q2 25 | $47.2M | $-14.1M | ||
| Q1 25 | $27.3M | $-53.1M | ||
| Q4 24 | $8.4M | $-29.1M | ||
| Q3 24 | $19.0M | $-27.4M | ||
| Q2 24 | $42.7M | $-33.4M | ||
| Q1 24 | $8.2M | $-36.0M |
毛利率HGTYOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率HGTYOFIX
| Q4 25 | 10.2% | 0.2% | ||
| Q3 25 | 9.0% | -8.3% | ||
| Q2 25 | 12.9% | -7.9% | ||
| Q1 25 | 8.1% | -25.2% | ||
| Q4 24 | 1.8% | -5.3% | ||
| Q3 24 | 3.1% | -9.6% | ||
| Q2 24 | 12.2% | -12.5% | ||
| Q1 24 | 4.5% | -15.6% |
净利率HGTYOFIX
| Q4 25 | 7.4% | -1.0% | ||
| Q3 25 | 12.2% | -11.1% | ||
| Q2 25 | 12.8% | -6.9% | ||
| Q1 25 | 8.5% | -27.4% | ||
| Q4 24 | 2.5% | -13.5% | ||
| Q3 24 | 5.9% | -13.9% | ||
| Q2 24 | 13.6% | -16.8% | ||
| Q1 24 | 3.0% | -19.1% |
每股收益（稀释后）HGTYOFIX
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.57 | ||
| Q2 25 | — | $-0.36 | ||
| Q1 25 | — | $-1.35 | ||
| Q4 24 | — | $-0.76 | ||
| Q3 24 | — | $-0.71 | ||
| Q2 24 | — | $-0.88 | ||
| Q1 24 | — | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $160.2M | $82.0M |
| 总债务越低越好 | $177.9M | — |
| 股东权益账面价值 | $221.3M | $450.0M |
| 总资产 | $2.1B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.80× | — |
8季度趋势，按日历期对齐
现金及短期投资HGTYOFIX
| Q4 25 | $160.2M | $82.0M | ||
| Q3 25 | $290.5M | $62.9M | ||
| Q2 25 | $259.6M | $65.6M | ||
| Q1 25 | $232.7M | $58.0M | ||
| Q4 24 | $178.7M | $83.2M | ||
| Q3 24 | $208.9M | $30.1M | ||
| Q2 24 | $186.4M | $26.4M | ||
| Q1 24 | $131.2M | $27.0M |
总债务HGTYOFIX
| Q4 25 | $177.9M | — | ||
| Q3 25 | $104.4M | $157.2M | ||
| Q2 25 | $153.4M | $157.0M | ||
| Q1 25 | $132.6M | $156.9M | ||
| Q4 24 | $105.8M | $157.0M | ||
| Q3 24 | $122.9M | $118.5M | ||
| Q2 24 | $98.0M | $118.0M | ||
| Q1 24 | $91.5M | $118.2M |
股东权益HGTYOFIX
| Q4 25 | $221.3M | $450.0M | ||
| Q3 25 | $211.7M | $442.5M | ||
| Q2 25 | $172.3M | $458.3M | ||
| Q1 25 | $162.9M | $458.3M | ||
| Q4 24 | $150.3M | $503.1M | ||
| Q3 24 | $148.3M | $525.9M | ||
| Q2 24 | $94.4M | $546.0M | ||
| Q1 24 | $93.5M | $570.3M |
总资产HGTYOFIX
| Q4 25 | $2.1B | $850.6M | ||
| Q3 25 | $2.2B | $832.6M | ||
| Q2 25 | $2.0B | $837.2M | ||
| Q1 25 | $1.8B | $823.1M | ||
| Q4 24 | $1.7B | $893.3M | ||
| Q3 24 | $1.8B | $867.9M | ||
| Q2 24 | $1.7B | $882.0M | ||
| Q1 24 | $1.6B | $906.0M |
负债/权益比HGTYOFIX
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.49× | 0.36× | ||
| Q2 25 | 0.89× | 0.34× | ||
| Q1 25 | 0.81× | 0.34× | ||
| Q4 24 | 0.70× | 0.31× | ||
| Q3 24 | 0.83× | 0.23× | ||
| Q2 24 | 1.04× | 0.22× | ||
| Q1 24 | 0.98× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $219.0M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $194.5M | $16.8M |
| 自由现金流率自由现金流/营收 | 50.1% | 7.6% |
| 资本支出强度资本支出/营收 | 6.3% | 4.9% |
| 现金转化率经营现金流/净利润 | 7.67× | — |
| 过去12个月自由现金流最近4个季度 | $365.8M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流HGTYOFIX
| Q4 25 | $219.0M | $27.7M | ||
| Q3 25 | $92.2M | $12.4M | ||
| Q2 25 | $53.9M | $11.6M | ||
| Q1 25 | $43.8M | $-18.4M | ||
| Q4 24 | $177.0M | $23.7M | ||
| Q3 24 | $67.4M | $11.7M | ||
| Q2 24 | $64.0M | $9.0M | ||
| Q1 24 | $58.2M | $-18.6M |
自由现金流HGTYOFIX
| Q4 25 | $194.5M | $16.8M | ||
| Q3 25 | $85.2M | $2.5M | ||
| Q2 25 | $47.7M | $4.5M | ||
| Q1 25 | $38.4M | $-25.1M | ||
| Q4 24 | $155.7M | $15.2M | ||
| Q3 24 | $62.0M | $6.3M | ||
| Q2 24 | $56.6M | $-360.0K | ||
| Q1 24 | $53.7M | $-29.1M |
自由现金流率HGTYOFIX
| Q4 25 | 50.1% | 7.6% | ||
| Q3 25 | 22.4% | 1.2% | ||
| Q2 25 | 12.9% | 2.2% | ||
| Q1 25 | 12.0% | -13.0% | ||
| Q4 24 | 46.7% | 7.0% | ||
| Q3 24 | 19.2% | 3.2% | ||
| Q2 24 | 18.1% | -0.2% | ||
| Q1 24 | 19.8% | -15.4% |
资本支出强度HGTYOFIX
| Q4 25 | 6.3% | 4.9% | ||
| Q3 25 | 1.8% | 4.8% | ||
| Q2 25 | 1.7% | 3.5% | ||
| Q1 25 | 1.7% | 3.5% | ||
| Q4 24 | 6.4% | 4.0% | ||
| Q3 24 | 1.7% | 2.7% | ||
| Q2 24 | 2.4% | 4.7% | ||
| Q1 24 | 1.7% | 5.6% |
现金转化率HGTYOFIX
| Q4 25 | 7.67× | — | ||
| Q3 25 | 2.00× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.61× | — | ||
| Q4 24 | 20.97× | — | ||
| Q3 24 | 3.55× | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 7.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HGTY
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
